NPs Basic Information

Name
Sarocladilactone A
Molecular Formula C31H42O8
IUPAC Name*
[6-hydroxy-17-[6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-4,8,10,14-tetramethyl-3,7-dioxo-5,6,9,11,12,13,15,16-octahydro-4H-cyclopenta[a]phenanthren-16-yl]acetate
SMILES
CC(=O)OC1CC2(C)C(CCC3C4(C)C=CC(=O)C(C)C4C(O)C(=O)C32C)C1=C1CCC(C(C)(C)O)OC1=O
InChI
InChI=1S/C31H42O8/c1-15-19(33)12-13-29(5)21-10-9-18-23(17-8-11-22(28(3,4)37)39-27(17)36)20(38-16(2)32)14-30(18,6)31(21,7)26(35)25(34)24(15)29/h12-13,15,18,20-22,24-25,34,37H,8-11,14H2,1-7H3/b23-17-/t15-,18+,20+,21+,22+,24-,25+,29-,30+,31-/m1/s1
InChIKey
GWXVBOPCGHPLPP-BIGPXKPTSA-N
Synonyms
NA
CAS NA
PubChem CID NA
ChEMBL ID NA
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Steroids and steroid deri
        • Subclass: Steroid lactones
          • Direct Parent: Steroid lactones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 542.67 ALogp: 3.5
HBD: 2 HBA: 8
Rotatable Bonds: 2 Lipinski's rule of five: Rejected
Polar Surface Area: 127.2 Aromatic Rings: 5
Heavy Atoms: 39 QED Weighted: 0.392

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.942 MDCK Permeability: 0.00001970
Pgp-inhibitor: 1 Pgp-substrate: 0.007
Human Intestinal Absorption (HIA): 0.011 20% Bioavailability (F20%): 0.222
30% Bioavailability (F30%): 0.885

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.963 Plasma Protein Binding (PPB): 80.85%
Volume Distribution (VD): 0.484 Fu: 23.27%

ADMET: Metabolism

CYP1A2-inhibitor: 0.006 CYP1A2-substrate: 0.116
CYP2C19-inhibitor: 0.021 CYP2C19-substrate: 0.798
CYP2C9-inhibitor: 0.071 CYP2C9-substrate: 0.071
CYP2D6-inhibitor: 0.001 CYP2D6-substrate: 0.111
CYP3A4-inhibitor: 0.508 CYP3A4-substrate: 0.391

ADMET: Excretion

Clearance (CL): 3.171 Half-life (T1/2): 0.116

ADMET: Toxicity

hERG Blockers: 0 Human Hepatotoxicity (H-HT): 0.108
Drug-inuced Liver Injury (DILI): 0.327 AMES Toxicity: 0.011
Rat Oral Acute Toxicity: 0.507 Maximum Recommended Daily Dose: 0.809
Skin Sensitization: 0.033 Carcinogencity: 0.042
Eye Corrosion: 0.003 Eye Irritation: 0.012
Respiratory Toxicity: 0.36
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003780 0.577 D0X7XG 0.301
ENC003846 0.557 D09WYX 0.289
ENC005154 0.525 D0D2TN 0.283
ENC005236 0.525 D0W2EK 0.269
ENC003847 0.522 D02JNM 0.265
ENC001480 0.479 D04SFH 0.265
ENC005487 0.469 D0F7NQ 0.265
ENC005155 0.460 D08IWD 0.262
ENC003484 0.459 D0K7HU 0.260
ENC005153 0.433 D0D1SG 0.259
*Note: the compound similarity was calculated by RDKIT.